Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.

MLA

Spahn, Jamie E., et al. “Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.” Pharmaceutics, vol. 16, no. 10, Oct. 2024, p. 1269. EBSCOhost, https://doi.org/10.3390/pharmaceutics16101269.

APA

Spahn, J. E., Hefnawy, A., Zhang, F., & Smyth, H. D. C. (2024). Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery. Pharmaceutics, 16(10), 1269. https://doi.org/10.3390/pharmaceutics16101269

Chicago

Spahn, Jamie E., Amr Hefnawy, Feng Zhang, and Hugh D. C. Smyth. 2024. “Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.” Pharmaceutics 16 (10): 1269. doi:10.3390/pharmaceutics16101269.